SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Profectus BioSciences, Inc.'s Vesicular Stomatitis Virus-Vectored HIV-1 Vaccine Safe and Immunogenic in Government Sponsored Phase 1 Trial